Weight loss drugs could add years to Americans' lives, researchers project
A new study has discovered that drugs can significantly reduce mortality for Americans for the Americans for a new study, diabetes and weight loss.
Swiss reinsurance company Swiss Re researchers in Switzerland, GLP-1 drugs until 2045 in the USA in the United States can lead to a reduction in all mortality of 6.4%.
In the UK, more than 5% decrease in mortality for the same 20 years is envisaged.
GLP-1 weight loss drugs like Özempic can be ‘everything medicine’?
Researchers said that they shared high obesity rates and “strong purchase” in the US and the UK’s GLP-1 drugs.
Since more than 40% of the adult population is obese, America has the highest obesity rate in the world. Approximately 30% of the UK adults are obese.
According to researchers, obesity is a factor that “stops progressing in life expectancy” because it depends on 70% of the leading causes of death in high -income countries. These reasons contain heart disease, stroke, alzheimer’s and many cancer.
“By improving the basic risk factors, GLP-1 drugs can contribute to mortality healing over time and save millions of people from early deaths.”
Why can microdozaneous ozempic be as common as taking a multivitamin?
In order to maximize the benefits of GLP-1 drugs, individuals should also apply lifestyle changes that support “long-term health improvements”.
Without sustainable changes such as studies, diet and exercise, weight recovery and recoil effects are common.
Paul Murray, CEO of Swiss Re’s Life & Health Reasures, interpreted these findings in a press release and said that GLP-1 drugs were “an important promise to help us overcome obesity epidemic”.
“Our research emphasizes that the full benefit will come from going beyond the drug.” “As insurers, we will establish partnerships, support politics and encourage meaningful lifestyle changes by focusing on preventing people.”
“If we do this right, we can strengthen the insurance security network and contribute to people who have longer, healthier lives.”
Click here to sign up for our health bulletin
Recent research has shown that GLP-1 drugs can improve various conditions beyond weight loss and diabetes.
These include heart, kidney, liver and skin conditions, as well as arthritis, cognitive decrease, addiction and even some cancers.
The tripartite board certified weight loss doctor in New York In an interview with FOX News Digital, Sue Decotiis confirmed how patients have experienced in various conditions in these drugs.
According to the specialist, fat cells burned with increased insulin drugs from GLP-1 drugs produce cytokines responsible for inflammation in the body and cause potentially autoimmune disease, cancer and other problems.
For more health articles, visit www.foxNews.com/health.
“We reduce the volume of fat cells in the body, we reduce all these inflammatory cytokines,” he said. “And that’s why we see many effects we see.”
He said: “It is important to do this correctly and to be really respectful to these drugs, to respect your body with respect and to understand that it is a great tool if it is used correctly.”
